REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/25/2025
Back to search
Official data from USPTO
SCANCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/25/2025
Trademark type
Word
Nice classes
5, 42
Filing date
06/24/2019
Registration date
02/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2020
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Oxford, GB
Examiner
MAHONEY, PAULA
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Scancell Limited
Representatives
Andrew D. Price VENABLE LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsfor the treatment of cancer; therapeutic preparations and substancesfor the treatment of cancer; chemical preparationsfor the treatment of cancer; diagnostic reagents for medical use; DNAantibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical usefor the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances; Therapeutic preparations and substances for medical useDNAantibodies and proteins for use in expressing epitopesfor use in encodingfor use in vectoring to target cellsfor use in stimulating cells; vaccinesincluding DNA vaccines; Therapeutic preparations for use in T-cell therapy and chimeric antigen receptor T-cell therapy to treat cancer
Class 42
Pharmaceutical testing and clinical trials for others; provision of information and consultancy in relation to the aforesaid services; scientific and technological servicesresearch and design in the field of drug development for the treatment of cancer; pharmaceutical research and development services; research and development in the biotechnology field; provision of information and consultancy in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
26 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/19/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/19/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/19/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/28/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/14/2019
GNSL
LETTER OF SUSPENSION E-MAILED
09/14/2019
CNSL
SUSPENSION LETTER WRITTEN
09/14/2019
DOCK
ASSIGNED TO EXAMINER
09/13/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/13/2019
ALIE
ASSIGNED TO LIE
08/08/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/01/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/03/2019
NWAP
NEW APPLICATION ENTERED
06/27/2019
Continuous trademark protection
Get notified about every new filing that threatens SCANCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.